Skip to content

A randomized controlled trial for the effect of yijing buyanghuanwu granules on macular retina choroidal thickness and blood flow of high myopia

A randomized controlled trial for the effect of yijing buyanghuanwu granules on macular retina choroidal thickness and blood flow of high myopia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017082
Enrollment
Unknown
Registered
2018-07-11
Start date
2018-08-15
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high myopia

Interventions

treatment group:Yijing Buyang Huanwu granules

Sponsors

Eye Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diopter=-6.00D; 2. Patients with highly myopia of qi deficiency and blood stasismeet 1 main symptom + 1 Secondary symptom; 3. Other vasodilators or neurotrophic drugs are being usedcan be included after stopping the medicine for a month; 4. informed consent signed.

Exclusion criteria

Exclusion criteria: 1. Patients with high myopic foveoschisis; 2. Patients with other fundus lesions; 3. Accompanied by heart, liver and kidney insufficiency; 4. Patients who are participating in other clinical trials of drugs or using similar traditional Chinese medicine and other treatments; 5. Subjects were reluctant to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score;Eye axis;Retinal thickness;Retinal blood flow;Choroid thickness;

Secondary

MeasureTime frame
Best corrected visual acuity;Equivalent spherical degree;

Countries

China

Contacts

Public ContactYin Lianrong

Eye Hospital of China Academy of Chinese Medical Sciences

yinlrye@126.com+86 13810710448

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026